CMND - Wutah pendapatan YoY sajrone 12 wulan kepungkur Clearmind Medicine Inc.

Tandha merek Clearmind Medicine (CMND)

Geopolitical tensions are restricting access to rare components and overseas testing, which impacts the costs of Clearmind Medicine Inc. (CMND). The rolling 12-month sales growth versus the previous year visualizes these processes, where the 0.00 mark indicates the current state. The company's prospects are based on synthetic molecules for treating alcoholism, and upcoming clinical trials remain the primary driver, which is already priced into the quotes.

CMND (Clearmind Medicine) riwayat Wutah dodolan YoY (TTM) saka 11.02.2024 nganti 19.11.2026

Ringkesan rincian data analitis Clearmind Medicine (CMND)

- nilai pasar lan prakiraan target analis:
Analisis kabeh metrik perusahaan:CMND - Clearmind Medicine
Produk asli clearmindmedicine.com

This indicator measures revenue dynamics over the last twelve months, allowing investors to assess the actual business scaling speed and the risk of overpaying for growth already priced in. By analyzing the annual growth rate of trailing twelve-month (LTM) revenue, one can diagnose the commercial effectiveness of Clearmind Medicine Inc. (CMND) psychopharmacological developments, where synergy with academic institutions in addiction treatment directly enhances the company's investment attractiveness for M&A.